About   Help   FAQ
Symbol
Name
ID
Apoe
apolipoprotein E
MGI:88057
Phenotype annotations related to homeostasis/metabolism
*Aspects of the system are reported to show a normal phenotype.
!Indicates phenotype varies with strain background.
Darker colors indicate more annotations
Human Phenotypes
Increased circulating IgA level
Increased circulating IgG level
Decreased circulating antibody level
Paraproteinemia
Abnormality of metabolism/homeostasis
Hypercalcemia
Hyperbilirubinemia
Increased LDL cholesterol concentration
Increased VLDL cholesterol concentration
Hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Elevated circulating creatinine concentration
Elevated circulating apolipoprotein A-II concentration
Elevated circulating apolipoprotein B concentration
Elevated circulating C-reactive protein concentration
Hyperproteinemia
Elevated circulating alanine aminotransferase concentration
Elevated circulating aspartate aminotransferase concentration
Glucose intolerance
Diabetes mellitus
Type II diabetes mellitus
Impaired glucose tolerance
Pleural effusion
Fever
Food intolerance
Abnormality of vitamin B12 metabolism
Amyloidosis
Disease(s) Associated with APOE
atopic dermatitis
coronary artery disease
familial combined hyperlipidemia
malaria
multiple myeloma
sea-blue histiocytosis
Sjogren's syndrome

Mouse Phenotypes
homeostasis/metabolism phenotype
decreased cardiac muscle triglyceride level
increased cholesterol efflux
decreased circulating homocysteine level
decreased circulating glucose level
increased circulating corticosterone level
decreased circulating insulin level
decreased circulating leptin level
abnormal circulating lipid level
abnormal circulating cholesterol level
decreased circulating HDL cholesterol level
increased circulating HDL cholesterol level
abnormal circulating LDL cholesterol level
increased circulating LDL cholesterol level
increased circulating VLDL cholesterol level
decreased circulating cholesterol level
increased circulating cholesterol level
increased circulating phospholipid level
decreased circulating triglyceride level
increased circulating triglyceride level
hyperlipidemia
abnormal circulating protein level
abnormal circulating apolipoprotein E level
abnormal glomerular capillary thrombosis
abnormal nitric oxide homeostasis
improved glucose tolerance
increased insulin sensitivity
abnormal lipid homeostasis
abnormal cholesterol homeostasis
decreased liver cholesterol level
decreased cholesterol level
increased cholesterol level
abnormal lipid level
increased prostaglandin level
decreased liver triglyceride level
decreased skeletal muscle triglyceride level
decreased triglyceride level
increased triglyceride level
xanthoma
abnormal enzyme/coenzyme activity
abnormal nucleotide metabolism
decreased cerebral infarct size
Availability Mouse Genotype
Apoeshl/Apoeshl ! !
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
Apoetm1.1Khw/Apoetm1.1Khw *
Apoetm1Bres/Apoetm1Bres
Apoetm1Khw/Apoetm1Khw
Apoetm1Lmh/Apoetm1Lmh
Apoetm1Unc/Apoetm1Unc
Apoetm1Unc/Apoetm1Unc
Tg(Cyp21a1-Apoe)614Fet/0
Apoetm1Unc/Apoetm1Unc
Tg(Cyp21a1-Apoe)619Fet/0
Apoetm4Mae/Apoetm4Mae
Apoeshl/Apoetm1Unc
Apoetm1Bres/Apoe+
Apoetm1Lmh/Apoe+
Apoetm1Unc/Apoe+
Tg(Cyp21a1-Apoe)614Fet/0
Tg(Cyp21a1-Apoe)619Fet/0
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0  (conditional)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory